Billionaire John Paulson posted the second-worst trading year of his career in 2014 as a wrong-way energy bet added to declines tied to a failed merger and investments in Fannie...
Keep Reading →
January 12 - Hedge Funds
Herbalife Ltd. (NYSE:HLF) is believed to be preparing to pursue legal proceedings against activist investor, Bill Ackman, over tirade comments made earlier last week.
Keep Reading →
January 12 - Hedge Funds, News, Tech
Good hedge-fund managers know to take some profits when they earn outsize returns.
Keep Reading →
January 9 - Hedge Funds
Aurelius Capital Management, one of the main plaintiffs against Argentina in New York District Judge Thomas Griesa’s courtroom, has denied being part in a lawsuit filed against...
Keep Reading →
January 7 - Hedge Funds
Hedge funds had a horrendous year in 2014 seen by more than 461 being shut down with only 2% being able to make substantial returns to investors. Despite the horrendous run, ...
Keep Reading →
January 7 - Hedge Funds, News
“2014 was also a very good year for activist investor Bill Ackman.
Keep Reading →
January 5 - Hedge Funds, News
In a new filing with the Securities and Exchange Commission, Jeff Ubben's ValueAct Capital reported increasing its position in Valeant Pharmaceuticals Intl Inc (NYSE:VRX).
Keep Reading →
November 28 - Hedge Funds, News
Ian Cumming and Joseph Steinberg’s Leucadia National Corp. (NYSE:LUK) disclosed a 12% increase in its exposure to Harbinger Group Inc (NYSE:HRG).
Keep Reading →
November 26 - Hedge Funds, News
As we continue to track insider transactions, I stumbled upon three more interesting purchases (check out some small-caps that insiders love).
Keep Reading →
November 25 - Insider Trading, News
One of the sectors that has benefited from the highest returns over the years is Healthcare.
Keep Reading →
November 19 - Hedge Funds, News
John Paulson clearly did not see the collapse of pharmaceutical giant AbbVie Inc (NYSE:ABBV)’s deal with rival Shire coming.
Keep Reading →
November 17 - Hedge Funds
Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) could lose out on a deal to acquire Botox Maker Allergan, Inc.
Keep Reading →
November 13 - News
As it was previously rumored in many sources, Bill Ackman's Pershing Square took a massive position in Zoetis Inc (NYSE:ZTS), as reported in a new filing with the US Securities...
Keep Reading →
November 12 - Hedge Funds, News
Wal-Mart Stores, Inc. (NYSE:WMT) has at least one investor excited about its short-term stock price prospect.
Keep Reading →
November 11 - Market Movers, News, Stock Analysis
Bill Ackman's intentions to acquire Allergan, Inc.
Keep Reading →
November 7 - Hedge Funds, News
The year is going Bill Ackman’s way especially when it comes to Herbalife Ltd.
Keep Reading →
November 5 - News, Stock Analysis
“Alright, Bill Ackman, I’ve been saying, ‘If you want to destroy a company, you know what, companies are fragile.
Keep Reading →
November 4 - Hedge Funds, Market Movers, News, Stock Analysis
The Madison Square Garden Company surprised many on Monday when it announced — besides exploring a potential breakup of itself — that it was adding two financiers to its board...
Keep Reading →
October 28 - Hedge Funds
Scott Ferguson's Sachem Head Capital has disclosed a new position in CDK Global Inc (NASDAQ:CDK), a company that was recently spun-off from Automatic Data Processing (NASDAQ...
Keep Reading →
October 28 - Hedge Funds, News
Bill Ackman is an American Hedge fund manager, who is the founder and CEO of Pershing Square Capital Management.
Keep Reading →
October 28 - Hedge Funds, News
Bill Ackman wants to clear up a few things.
Keep Reading →
October 24 - Hedge Funds
David Tepper, the founder of hedge fund Appaloosa Management, said that he’s short the euro during a talk at the Robin Hood Investors Conference in New York City.
Keep Reading →
October 22 - Hedge Funds
The best thing federal prosecutors might have done for Steven A.
Keep Reading →
October 16 - Hedge Funds
Bill Ackman is one of the most notorious activist investors on Wall Street, which is why his moves are followed closely. Recently, Mr.
Keep Reading →
October 14 - Hedge Funds, News
The global market for initial public offerings has had a patchy year at best and activist investor Bill Ackman’s latest foray into the arena may not be remembered as a highlight...
Keep Reading →
October 13 - Hedge Funds
Bill Ackman is bullish on Platform Specialty Products Corp (NYSE:PAH) and with his recent activist move on the stock, the company could grow even further.
Keep Reading →
October 8 - Hedge Funds, News
Ken Griffin's $24 billion Citadel gained 4.4% in September, easily outstripping the average hedge fund which fell 0.2% last month.
Keep Reading →
October 7 - Hedge Funds
Eric Mindich (Trades, Portfolio), founder of hedge fund Eton Park and famous for becoming at age 27 the youngest partner at Goldman Sachs Group, Inc.
Keep Reading →
October 1 - Hedge Funds
Security and Exchange Commission has charged two men with insider trading in Herbalife Ltd. (NYSE:HLF) shares, according to a CNBC report by Scott Wapner.
Keep Reading →
September 30 - Hedge Funds, News
Jeffrey Ubben’s Valueact Capital Management disclosed today an increase in its exposure to Valeant Pharmaceuticals Intl Inc (NYSE:VRX).
Keep Reading →
September 25 - Hedge Funds, News
The activist hedge fund firms that have been pushing for change at Sothebys (NYSE:BID) may have won their big boardroom battle. But they may be losing the war.
Keep Reading →
September 24 - Hedge Funds
In a new filing with the Securities and Exchange Commission, Pershing Square Capital Management revealed a letter signed by its Chief Executive Officer, Bill Ackman, addressed...
Keep Reading →
September 24 - Hedge Funds, News
Herbalife Ltd. (NYSE:HLF)’s up by about 7% during the day and trades at around $43.1, after a long slide that started at the end of July.
Keep Reading →
September 23 - News
Avenue Capital Group LLC, the U.S.
Keep Reading →
September 23 - Hedge Funds
Ray Dalio, who runs the $160 billion Bridgewater Associates LP, said he’s seeking to encourage a culture of “radical truth and radical transparency” by recording everything...
Keep Reading →
September 22 - Hedge Funds
Established back in April 1997, Rima Senvest Management boasts an annualized return of 20% per year and has currently been on a wave, racking up a return of approximately 80...
Keep Reading →
September 18 - Hedge Funds, News
Pershing Square, managed by Bill Ackman and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) have entered into an agreement with Allergan Inc.
Keep Reading →
September 17 - Hedge Funds, News
On 18th December the winner of the epic corporate battle between Allergan, Inc.
Keep Reading →
September 16 - Earnings Report, News, Stock Analysis
Minnesota Wild co-owner Phil Falcone might quit his hockey-crazed home state to make a play for the New York Islanders, The Post has learned.
Keep Reading →
September 15 - Hedge Funds
Whenever Icahn Enterprises LP (NASDAQ:IEP) founder, Carl Icahn, speaks about his investments and investment style, there are things one can learn, which are rarely found in investment...
Keep Reading →
September 15 - Hedge Funds, News
Bill Ackman does not show any signs of giving up on the proposed takeover of Allergan, Inc. (NYSE:AGN) by Valeant Pharmaceuticals Intl Inc (NYSE:VRX).
Keep Reading →
September 10 - Hedge Funds, News
Hedge fund boss gives £5 million to build new museum maths gallery (Standard) A hedge fund manager who built his business on mathematical reasoning has given the Science Museum...
Keep Reading →
September 10 - Hedge Funds
40 North Management, managed by David S. Winter and David J. Millstone, recently filed its 13F with the U.S. Securities and Exchange Commission.
Keep Reading →
September 8 - Hedge Funds, News
CNBC's David Faber delivered the news that Allergan, Inc. (NYSE:AGN) is going to have a special shareholders' meeting on December 18th.
Keep Reading →
September 4 - Hedge Funds, News
Kenneth Squire’s 13D Management recently filed with the SEC its 13F for the second quarter of 2014.
Keep Reading →
August 29 - Hedge Funds
Pavle Sabic, financial risk manager at S&P Capital IQ, in an interview on CNBC discussed the stocks that hedge funds have been most bulish on. The top company is Allergan Inc.
Keep Reading →
August 29 - Hedge Funds, News, Tech
In a new filing with the U.S.
Keep Reading →
August 28 - Hedge Funds, News
Manhattan US Attorney Preet Bharara has asked the Securities and Exchange Commission to hold off on its decision about former hedge-fund kingpin Steve Cohen for three more months...
Keep Reading →
August 27 - Hedge Funds